Laparoscopic liver resection in metastatic colorectal cancer

Kolesnik, O.; Lukashenko, A.; Ostapenko, Yuriy; Chorna, N.; Patsko, V.

doi:10.1093/annonc/mdz155.360

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…60% of CRC patients have liver metastases, about 80%-90% of which are unresectable [3]. The failure to perform metastasectomy is associated with a worse prognosis: the 5-year survival in this case is only 6%-10% [4,5].…”

Section: Case Reportsmentioning

confidence: 92%

Intra-Arterial Chemotherapy as a Clinical Option for Metastatic Colorectal Cancer: Conversion of Inoperable Liver Metastases to Operable Illustrated With a Clinical Case

Cherchenko,

Lukashenko,

Ostapenko

et al. 2024

Exp. oncol.

View full text Add to dashboard Cite

Colorectal cancer exerts a very high level of liver metastases, even on primary diagnosis, with 80%—90% unresectable nodules. At the same time, the possibility of resection has a significant impact on survival: 5-year survival is 6%—10% without liver surgery and up to 30% upon resection of liver metastases. Finding ways to improve resectability is a topical search for doctors all over the world. One of the promising methods to convert unresectable liver metastases of colorectal cancer into resectable ones is a hepatic artery infusion, or intra-arterial chemotherapy allowing for the delivery of cytotoxic drugs directly to the common hepatic artery via catheter or pump with decreased systemic toxicity and increased local drug concentration. In this article, we discuss the literature data on the impact of intra-arterial chemotherapy on the resectability of colorectal metastases in the liver and present the results of the successful clinical case. The literature shows a positive impact of the hepatic artery infusion on the resectability of hepatic metastases of colorectal cancer. The National Cancer Institute (Ukraine) has its own experience in hepatic artery infusion with further resection of primary-unresectable colorectal metastases in the liver. In our clinical case, a patient with liver-limited metastasis of colorectal cancer was initially inoperable due to the size of tumor lesions and an insufficient residual volume of the liver. Hepatic artery infusion tactics was chosen for this patient. The patient received six cycles of intra-arterial chemotherapy, namely five FOLFOX cycles and one 5-FU cycle, and then met the resectability criteria. Also, it is important to notice that the case demonstrates chemoresistance overcoming, since the patient had disease progression before, following systemically administered XELOX, and the period until readmission of the drugs was less than 6 months. So, hepatic artery infusion can be considered a promising method to convert unresectable liver metastases of colorectal cancer into resectable ones for highly selected patients.

show abstract

Section: Case Reportsmentioning

confidence: 92%